CompletedPhase 2NCT00003811
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Neyssa M. Marina, MDStanford University
- Intervention
- bleomycin sulfate(biological)
- Enrollment
- 27 enrolled
- Eligibility
- 14 years · All sexes
- Timeline
- 2000 – 2007
Study locations (30)
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
- MBCCOP - Gulf Coast, Mobile, Alabama, United States
- Arizona Cancer Center, Tucson, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- University of California San Diego Cancer Center, La Jolla, California, United States
- Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States
- Sutter Cancer Center, Sacramento, California, United States
- University of California Davis Medical Center, Sacramento, California, United States
- Kaiser Permanente-Southern California Permanente Medical Group, San Diego, California, United States
- Children's Hospital and Health Center, San Diego, California, United States
- Naval Medical Center - San Diego, San Diego, California, United States
- Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States
- Stanford University Medical Center, Stanford, California, United States
- Yale Comprehensive Cancer Center, New Haven, Connecticut, United States
- Walter Reed Army Medical Center, Washington D.C., District of Columbia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003811 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology